UG Healthcare (SGX:8K7) Other Current Payables: S$0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is UG Healthcare Other Current Payables?

UG Healthcare SGX:8K7 -9.88% Other Current Payables is S$0.0 Mil as of Jun. 2026. The stock has 8 warning signs investors should review.

UG Healthcare's Other Current Payables for the quarter that ended in Jun. 2026 was S$0.0 Mil.

UG Healthcare's quarterly Other Current Payables declined from Jun. 2025 (S$2.7 Mil) to Dec. 2025 (S$-0.0 Mil) but then increased from Dec. 2025 (S$-0.0 Mil) to Jun. 2026 (S$0.0 Mil).

UG Healthcare's annual Other Current Payables increased from Jun. 2024 (S$2.6 Mil) to Jun. 2025 (S$2.7 Mil) but then declined from Jun. 2025 (S$2.7 Mil) to Jun. 2026 (S$0.0 Mil).


UG Healthcare Other Current Payables Related Terms


UG Healthcare Other Current Payables Historical Data

* Premium members only.

The historical data trend for UG Healthcare's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UG Healthcare Other Current Payables Chart

UG Healthcare Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.30 2.85 2.61 2.73 0.00

UG Healthcare Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.61 0.00 2.73 -0.00 0.00

UG Healthcare Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of S$0.0 Mil mean?
UG Healthcare (SGX:8K7) has a Other Current Payables of S$0.0 Mil as of Jun. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on UG Healthcare and its competitors.
Is UG Healthcare's Other Current Payables too high?
UG Healthcare's current Other Current Payables is S$0.0 Mil.
How does UG Healthcare's Other Current Payables compare to ISRG and BDX?
UG Healthcare's Other Current Payables of S$0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on UG Healthcare and its competitors. UG Healthcare's current Other Current Payables is S$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UG Healthcare stock overvalued right now?
Based on GuruFocus' analysis, UG Healthcare (SGX:8K7) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.13, compared to a current price of S$0.07 — trading 43.8% below its estimated fair value. The current Other Current Payables is S$0.0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For UG Healthcare (SGX:8K7), the current Other Current Payables is S$0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

UG Healthcare Business Description

Address 38 Beach Road, No. 29-11, South Beach Tower, Singapore, SGP, 189767
UG Healthcare Corp Ltd is a rubber gloves manufacturer. The company manufactures and distributes products under the Unigloves brand as well as Original Equipment Manufacturer (OEM). The company's business segments are latex examination gloves, nitrile examination gloves, and other ancillary products. It also offers vinyl gloves, surgical gloves and cleanroom gloves, face masks, and other medical disposables. It has two manufacturing plants located in Seremban, Malaysia. Its gloves are used in medical and healthcare, food and beverage, R&D, Industrials and beauty industry. It has a geographical presence with the majority of the revenue generated from Europe.